UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021322
Receipt number R000024594
Scientific Title intravenous remifentanil analgesia during labor and decreasing maternal respiratory depression with mosaprid
Date of disclosure of the study information 2016/04/01
Last modified on 2019/03/25 09:31:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

intravenous remifentanil analgesia during labor and decreasing maternal respiratory depression with mosaprid

Acronym

remifentanil analgesia during labor and decreasing maternal respiratory depression with mosaprid

Scientific Title

intravenous remifentanil analgesia during labor and decreasing maternal respiratory depression with mosaprid

Scientific Title:Acronym

remifentanil analgesia during labor and decreasing maternal respiratory depression with mosaprid

Region

Japan


Condition

Condition

pain of labor

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Study of decreasing opioid related maternal respiratory depression with mosaprid

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

pain control, the presence or absence of maternal respiratory depression

Key secondary outcomes

Drug administration time, drug bolus administration number of times, the presence or absence of labor induction, patient satisfaction, final delivery mode, Apgar score, the presence or absence of umbilical cord arterial blood pH, birth weight, neonatal complications


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

mosaprid administration
mosaprid 5mg per every 4 hours during first labor phase

Interventions/Control_2

no treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

pregnant women who wish to relief labor pain patient obtained a consent with this study

Key exclusion criteria

Patients who can not consent.
Patient information can not be obtained necessary for analysis.
Patients of less than 22 weeks of pregnancy the fetus is alive.
Patients with a merger or a history of a high degree of hypersensitivity reactions to other drugs.
Patients with impaired consciousness.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Kondoh

Organization

Kyoto University

Division name

Department of Gynecology and Obstetrics

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto

TEL

075-751-3269

Email

kondo@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Shingo
Middle name
Last name Io

Organization

Kyoto University

Division name

Department of Gynecology and Obstetrics

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto

TEL

075-751-3269

Homepage URL


Email

shinio@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Department of Gynecology and Obstetrics

Institute

Department

Personal name



Funding Source

Organization

Kyoto University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kurashiki Central Hospital Department of Obstetrics and Gynecology
Mitsubishi Kyoto Hospital Department of Obstetrics and Gynecology
Kosaka womens hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committe of Kyoto University Hospital

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院産科婦人科(京都府), 倉敷中央病院産婦人科(岡山県), 三菱京都病院産婦人科(京都府), 小阪産病院産婦人科(大阪府)


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

150

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 03 Month 15 Day

Date of IRB

2016 Year 04 Month 05 Day

Anticipated trial start date

2016 Year 06 Month 01 Day

Last follow-up date

2019 Year 03 Month 10 Day

Date of closure to data entry

2019 Year 03 Month 12 Day

Date trial data considered complete

2019 Year 03 Month 12 Day

Date analysis concluded

2019 Year 03 Month 14 Day


Other

Other related information



Management information

Registered date

2016 Year 03 Month 03 Day

Last modified on

2019 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024594